Millinette

Do not take Millinette if you have, or have had:

• Presence or risk of venous thromboembolism (VTE)
• Venous thromboembolism – current VTE (on anticoagulants) or history of (e.g. deep venous thrombosis [DVT] or pulmonary embolism [PE]).
• A Known hereditary or acquired predisposition for venous thromboembolism, such as APC-resistance, (including Factor V Leiden), antithrombin-III-deficiency, protein C deficiency, protein S deficiency.
• Major surgery with prolonged immobilisation
• A high risk of venous thromboembolism due to the presence of multiple risk factors.
• Presence or risk of arterial thromboembolism (ATE)
• Arterial thromboembolism – current arterial thromboembolism, history of arterial thromboembolism (e.g. myocardial infarction) or prodromal condition (e.g. angina pectoris).
• Cerebrovascular disease – current stroke, history of stroke or prodromal condition (e.g. transient ischaemic attack, TIA).
• Known hereditary or acquired predisposition for arterial thromboembolism, such as hyperhomocysteinaemia and antiphospholipid-antibodies (anticardiolipin-antibodies, lupus anticoagulant).
• History of migraine with focal neurological symptoms.
• A high risk of arterial thromboembolism due to multiple risk factors, or to the presence of one serious risk factor such as:
• Diabetes mellitus with vascular symptoms
• Severe hypertension
• Severe dyslipoproteinaemia.
• Pancreatitis or a history thereof if associated with severe hypertriglyceridemia
• Presence or history of severe hepatic disease as long as liver function values have not returned to normal.
• Presence or history of liver tumours (benign or malignant).
• Known or suspected sex steroid-influenced malignancies (e.g. of the genital organs or the breasts)
• Endometrial hyperplasia
• Undiagnosed vaginal bleeding.
• Known or suspected pregnancy.
• Allergy to the active ingredients

Patient Information Leaflet enclosed with your medicines for a full list of medicines that may affect your contraceptive pill.